TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RNA

Atrium Therapeutics, Inc.

Healthcare · Biotechnology

8.40$ +1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RNA
Line item 2011 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
– – – 0.02 0.06 0.31 0.23 0.18 0.13 0.10 1.09
– – – 0.41 0.39 1.74 0.02 0.03 0.03 0.02 0.24
– – – -0.39 0.06 0.31 0.23 0.18 0.10 0.10 1.09
– – – 0.41 0.39 1.74 2.44 2.88 2.62 2.72 3.14
– – – 0.12 0.14 0.62 0.63 0.72 0.74 0.77 2.44
– – – 0.53 0.52 2.36 3.07 3.61 3.33 3.49 5.58
– – – -0.51 -0.46 -2.04 -2.85 -3.43 -3.23 -3.40 -4.49
– – – 0.03 0.20 0.01 0.02 0.11 – – –
– – – -0.54 -0.66 -2.05 -2.85 -3.34 -2.91 -2.89 -4.49
– – – 0.03 0.20 -0.02 -0.02 -0.09 0.03 – -0.01
– – – -0.58 -0.66 -2.03 -2.83 -3.24 -2.91 -2.89 -4.48
– – – -0.49 -0.45 -2.03 -2.83 -3.40 -3.20 -3.37 -4.47

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?